LY3819469

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3819469, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] [Phase 2]